A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

While everyone's at risk for high blood sugar levels after surgery, people with diabetes face even greater risks. While the exact reason for this cannot always be determined, there are a few different ...

About one out of every eight adults in the U.S. has taken a GLP-1 medication, such as Trulicity, Ozempic, Rybelsus or Mounjaro — and half of these people are still ...

What it means for patients - The compounded versions of the drug were originally sold to combat a brand-name shortage ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like Ozempic and Wegovy. In phase III trials it significantly lowered blood sugar ...